Back
Galectin Therapeutics Stock Price Chart
Sponsored
GALT
Sponsored
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
16
GALT
Galectin Therapeutics
Last Price:
$0.87
Seasonality Move:
33.46%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GALT is experiencing slight buying pressure.
Galectin Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.66 | Sell |
20-day SMA: | 2.07 | Sell |
50-day SMA: | 2.44 | Sell |
200-day SMA: | 2.63 | Sell |
8-day EMA: | 1.47 | Sell |
20-day EMA: | 1.92 | Sell |
50-day EMA: | 2.28 | Sell |
200-day EMA: | 2.43 | Sell |
Galectin Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.38 | Sell |
Relative Strength Index (14 RSI): | 18.99 | Sell |
Chaikin Money Flow: | 563571 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.62 - 2.8) | Sell |
Bollinger Bands (100): | (2.09 - 2.87) | Sell |
Galectin Therapeutics Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Galectin Therapeutics Stock
Is Galectin Therapeutics Stock a Buy?
-
Galectin Therapeutics share price is 0.84 while GALT 8-day simple moving average is 1.66, which is a Sell signal.
-
The stock price of GALT is 0.84 while Galectin Therapeutics 20-day SMA is 2.07, which makes it a Sell.
-
Galectin Therapeutics 50-day simple moving average is 2.44 while GALT share price is 0.84, making it a Sell technically.
-
GALT stock price is 0.84 and Galectin Therapeutics 200-day simple moving average is 2.63, creating a Sell signal.
GALT Technical Analysis vs Fundamental Analysis
Sell
16
Galectin Therapeutics (GALT)
is a Sell
Is Galectin Therapeutics a Buy or a Sell?
-
Galectin Therapeutics stock is rated a SellThe current Galectin Therapeutics [GALT] share price is $0.84. The Score for GALT is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
Galectin Therapeutics Stock Info
Market Cap:
52.8M
Price in USD:
0.84
Share Volume:
1.7M
Galectin Therapeutics 52-Week Range
52-Week High:
4.27
52-Week Low:
0.73
Sell
16
Galectin Therapeutics (GALT)
is a Sell
Galectin Therapeutics Share Price Forecast
-
What is the Galectin Therapeutics stock price today?The Galectin Therapeutics stock price is 0.84 USD today.
-
Will GALT stock go up or go down?Galectin Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Galectin Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Galectin Therapeutics is overvalued.
Is Galectin Therapeutics Stock a Buy?
-
Galectin Therapeutics share price is 0.84 while GALT 8-day exponential moving average is 1.47, which is a Sell signal.
-
The stock price of GALT is 0.84 while Galectin Therapeutics 20-day EMA is 1.92, which makes it a Sell.
-
Galectin Therapeutics 50-day exponential moving average is 2.28 while GALT share price is 0.84, making it a Sell technically.
-
GALT stock price is 0.84 and Galectin Therapeutics 200-day simple moving average is 2.43, creating a Sell signal.
Technical Analysis of Galectin Therapeutics
Should I short Galectin Therapeutics stock?
-
GALT Moving Average Covergence Divergence (MACD) indicator is -0.38, suggesting Galectin Therapeutics is a Sell
-
Galectin Therapeutics Relative Strength Index (RSI) is 18.99, which suggest Galectin Therapeutics is oversold
-
The Bollinger Bands (25) for Galectin Therapeutics is (1.62 - 2.8), which suggest Galectin Therapeutics is a Sell
-
The Bollinger Bands (100) for Galectin Therapeutics is (2.09 - 2.87), which suggest Galectin Therapeutics is a Sell
* Galectin Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.